nodes	percent_of_prediction	percent_of_DWPC	metapath
Pentamidine—CYP2C19—Methimazole—Graves' disease	0.24	0.316	CbGbCtD
Pentamidine—CYP1A2—Methimazole—Graves' disease	0.221	0.291	CbGbCtD
Pentamidine—CYP2D6—Methimazole—Graves' disease	0.182	0.24	CbGbCtD
Pentamidine—CYP3A4—Methimazole—Graves' disease	0.116	0.153	CbGbCtD
Pentamidine—Splenomegaly—Propylthiouracil—Graves' disease	0.0257	0.109	CcSEcCtD
Pentamidine—Nephritis—Methimazole—Graves' disease	0.0245	0.105	CcSEcCtD
Pentamidine—Nephritis—Propylthiouracil—Graves' disease	0.0209	0.0889	CcSEcCtD
Pentamidine—Interstitial pneumonia—Propylthiouracil—Graves' disease	0.0147	0.0628	CcSEcCtD
Pentamidine—Ageusia—Methimazole—Graves' disease	0.0103	0.0441	CcSEcCtD
Pentamidine—Interstitial lung disease—Propylthiouracil—Graves' disease	0.0101	0.0429	CcSEcCtD
Pentamidine—Ageusia—Propylthiouracil—Graves' disease	0.00879	0.0375	CcSEcCtD
Pentamidine—Vasculitis—Propylthiouracil—Graves' disease	0.0073	0.0311	CcSEcCtD
Pentamidine—Renal failure acute—Propylthiouracil—Graves' disease	0.0056	0.0239	CcSEcCtD
Pentamidine—Drowsiness—Methimazole—Graves' disease	0.00469	0.02	CcSEcCtD
Pentamidine—Neuropathy peripheral—Methimazole—Graves' disease	0.00459	0.0196	CcSEcCtD
Pentamidine—Hepatitis—Methimazole—Graves' disease	0.00421	0.0179	CcSEcCtD
Pentamidine—Drowsiness—Propylthiouracil—Graves' disease	0.00399	0.017	CcSEcCtD
Pentamidine—Neuropathy peripheral—Propylthiouracil—Graves' disease	0.00391	0.0166	CcSEcCtD
Pentamidine—Hepatitis—Propylthiouracil—Graves' disease	0.00358	0.0152	CcSEcCtD
Pentamidine—Vertigo—Methimazole—Graves' disease	0.00329	0.014	CcSEcCtD
Pentamidine—Leukopenia—Methimazole—Graves' disease	0.00328	0.014	CcSEcCtD
Pentamidine—Myalgia—Methimazole—Graves' disease	0.00312	0.0133	CcSEcCtD
Pentamidine—Arthralgia—Methimazole—Graves' disease	0.00312	0.0133	CcSEcCtD
Pentamidine—Dysgeusia—Propylthiouracil—Graves' disease	0.00305	0.013	CcSEcCtD
Pentamidine—Thrombocytopenia—Methimazole—Graves' disease	0.00293	0.0125	CcSEcCtD
Pentamidine—Vertigo—Propylthiouracil—Graves' disease	0.0028	0.0119	CcSEcCtD
Pentamidine—Leukopenia—Propylthiouracil—Graves' disease	0.00279	0.0119	CcSEcCtD
Pentamidine—Musculoskeletal discomfort—Methimazole—Graves' disease	0.00272	0.0116	CcSEcCtD
Pentamidine—Paraesthesia—Methimazole—Graves' disease	0.00268	0.0114	CcSEcCtD
Pentamidine—Somnolence—Methimazole—Graves' disease	0.00266	0.0113	CcSEcCtD
Pentamidine—Arthralgia—Propylthiouracil—Graves' disease	0.00265	0.0113	CcSEcCtD
Pentamidine—Myalgia—Propylthiouracil—Graves' disease	0.00265	0.0113	CcSEcCtD
Pentamidine—Dyspepsia—Methimazole—Graves' disease	0.00263	0.0112	CcSEcCtD
Pentamidine—Thrombocytopenia—Propylthiouracil—Graves' disease	0.00249	0.0106	CcSEcCtD
Pentamidine—Urticaria—Methimazole—Graves' disease	0.00237	0.0101	CcSEcCtD
Pentamidine—Body temperature increased—Methimazole—Graves' disease	0.00236	0.0101	CcSEcCtD
Pentamidine—Musculoskeletal discomfort—Propylthiouracil—Graves' disease	0.00232	0.00987	CcSEcCtD
Pentamidine—Paraesthesia—Propylthiouracil—Graves' disease	0.00228	0.00973	CcSEcCtD
Pentamidine—Somnolence—Propylthiouracil—Graves' disease	0.00226	0.00963	CcSEcCtD
Pentamidine—Dyspepsia—Propylthiouracil—Graves' disease	0.00224	0.00953	CcSEcCtD
Pentamidine—Pruritus—Methimazole—Graves' disease	0.00211	0.00901	CcSEcCtD
Pentamidine—Urticaria—Propylthiouracil—Graves' disease	0.00202	0.0086	CcSEcCtD
Pentamidine—Body temperature increased—Propylthiouracil—Graves' disease	0.00201	0.00856	CcSEcCtD
Pentamidine—Vomiting—Methimazole—Graves' disease	0.0019	0.0081	CcSEcCtD
Pentamidine—Rash—Methimazole—Graves' disease	0.00188	0.00803	CcSEcCtD
Pentamidine—Dermatitis—Methimazole—Graves' disease	0.00188	0.00802	CcSEcCtD
Pentamidine—Headache—Methimazole—Graves' disease	0.00187	0.00798	CcSEcCtD
Pentamidine—Pruritus—Propylthiouracil—Graves' disease	0.0018	0.00766	CcSEcCtD
Pentamidine—Nausea—Methimazole—Graves' disease	0.00178	0.00757	CcSEcCtD
Pentamidine—Vomiting—Propylthiouracil—Graves' disease	0.00162	0.00689	CcSEcCtD
Pentamidine—Rash—Propylthiouracil—Graves' disease	0.0016	0.00683	CcSEcCtD
Pentamidine—Dermatitis—Propylthiouracil—Graves' disease	0.0016	0.00682	CcSEcCtD
Pentamidine—Headache—Propylthiouracil—Graves' disease	0.00159	0.00678	CcSEcCtD
Pentamidine—AOC1—connective tissue—Graves' disease	0.00153	0.242	CbGeAlD
Pentamidine—Nausea—Propylthiouracil—Graves' disease	0.00151	0.00643	CcSEcCtD
Pentamidine—S100B—eye—Graves' disease	0.00139	0.219	CbGeAlD
Pentamidine—S100B—connective tissue—Graves' disease	0.00134	0.211	CbGeAlD
Pentamidine—S100B—adipose tissue—Graves' disease	0.00103	0.162	CbGeAlD
Pentamidine—CYP2C8—pituitary gland—Graves' disease	0.000241	0.038	CbGeAlD
Pentamidine—CYP1A1—adipose tissue—Graves' disease	0.000222	0.0349	CbGeAlD
Pentamidine—CYP3A5—adipose tissue—Graves' disease	0.000217	0.0341	CbGeAlD
Pentamidine—CYP1A2—thyroid gland—Graves' disease	0.000194	0.0306	CbGeAlD
Pentamidine—CYP1A1—thyroid gland—Graves' disease	0.000192	0.0302	CbGeAlD
